耐用性、耐容性、認容性、許容性、許容度
- 関
- acceptability、acceptance、allowance、permissivity、tolerance、tolerant
WordNet
- the act of tolerating something
- the power or capacity of an organism to tolerate unfavorable environmental conditions
- willingness to recognize and respect the beliefs or practices of others
- a permissible difference; allowing some freedom to move within limits (同)leeway, margin, tolerance
- the act of allowing; "He objected to the allowance of smoking in the dining room"
- an amount added or deducted on the basis of qualifying circumstances; "an allowance for profit" (同)adjustment
- a sum granted as reimbursement for expenses
- an amount allowed or granted (as during a given period); "travel allowance"; "my weekly allowance of two eggs"; "a childs allowance should not be too generous"
- put on a fixed allowance, as of food
- the act of taking something that is offered; "her acceptance of the gift encouraged him"; "he anticipated their acceptance of his offer"
- banking: a time draft drawn on and accepted by a bank (同)banker''s acceptance
- the state of being acceptable and accepted; "torn jeans received no acceptance at the country club"
- (contract law) words signifying consent to the terms of an offer (thereby creating a contract)
- showing respect for the rights or opinions or practices of others
- showing the capacity for endurance; "injustice can make us tolerant and forgiving"; "a man patient of distractions" (同)patient of
- able to tolerate environmental conditions or physiological stress; "the plant is tolerant of saltwater"; "these fish are quite tolerant as long as extremes of pH are avoided"; "the new hybrid is more resistant to drought" (同)resistant
- satisfactoriness by virtue of conforming to approved standards (同)acceptableness
PrepTutorEJDIC
- (自分と異なる他人の意見・行動などを許す)寛大,寛容・我慢(がまん),忍耐力 / (薬品・毒物などに対する)耐性,抗毒性 / 公差,許容誤差
- 『割り当て』;(定期的な)手当,こづかい / 値引き,割引き
- 〈U〉受け取ること,認めること,受け入れられていること;同意 / 〈U〉(手形の)引受け;〈C〉引受済み手形
- 寛大な,寛容な;(…に)寛大な《+of(to)+名》 / (薬品・毒物などの作用に)耐性がある,抵抗力のある
- 受け入れられること,受容性
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/11/24 23:17:47」(JST)
[Wiki en表示]
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (November 2013) (Learn how and when to remove this template message) |
Tolerability refers to the degree to which overt adverse effects of a drug can be tolerated by a patient.[1] Tolerability of a particular drug can be discussed in a general sense, or it can be a quantifiable measurement as part of a clinical study. Usually, it is measured by the rate of "dropouts," or patients that forfeit participation in a study due to extreme adverse effects. Tolerability, however, is often relative to the severity of the medical condition a drug is designed to treat.[1] For instance, cancer patients will generally tolerate an immense amount of pain or discomfort during a chemotherapeutic study with the hope of prolonging survival or finding a cure, whereas patients experiencing a benign condition, such as a headache, will not.
As an example, tricyclic antidepressants (TCAs) are very poorly tolerated and often produce severe side effects including sedation, orthostatic hypotension, and anticholinergic effects, whereas newer antidepressants have far fewer adverse effects and are well tolerated.
See also
References
- ^ a b Ton, Nu Thanh Huyen; Hartstra, Jan; Persiani, Stefano; Beckert, Michael. "Safety - Tolerability". PharmPK Discussion. David W.A. Bourne. Retrieved 13 November 2013.
Medicine
|
|
|
|
Specialties
and
subspecialties |
Surgery
|
|
- Cardiac surgery
- Cardiothoracic surgery
- Colorectal surgery
- Eye surgery
- General surgery
- Neurosurgery
- Oral and maxillofacial surgery
- Orthopedic surgery
- Hand surgery
- Otolaryngology (ENT)
- Pediatric surgery
- Plastic surgery
- Reproductive surgery
- Surgical oncology
- Thoracic surgery
- Transplant surgery
- Trauma surgery
- Urology
- Vascular surgery
|
Internal medicine
|
|
- Allergy / Immunology
- Angiology
- Cardiology
- Endocrinology
- Gastroenterology
- Geriatrics
- Hematology
- Hospital medicine
- Infectious disease
- Nephrology
- Oncology
- Pulmonology
- Rheumatology
|
Obstetrics and gynaecology
|
|
- Gynaecology
- Gynecologic oncology
- Maternal–fetal medicine
- Obstetrics
- Reproductive endocrinology and infertility
- Urogynecology
|
Diagnostic
|
|
- Radiology
- Interventional radiology
- Nuclear medicine
- Pathology
- Anatomical pathology
- Clinical pathology
- Clinical chemistry
- Clinical immunology
- Cytopathology
- Medical microbiology
- Transfusion medicine
|
Other specialties
|
|
- Addiction medicine
- Adolescent medicine
- Anesthesiology
- Dermatology
- Disaster medicine
- Diving medicine
- Emergency medicine
- Family medicine
- General practice
- Hospital medicine
- Intensive-care medicine
- Medical genetics
- Neurology
- Occupational medicine
- Ophthalmology
- Oral medicine
- Pain management
- Palliative care
- Pediatrics
- Physical medicine and rehabilitation (PM&R)
- Preventive medicine
- Psychiatry
- Radiation oncology
- Reproductive medicine
- Sexual medicine
- Sleep medicine
- Sports medicine
- Transplantation medicine
- Tropical medicine
- Venereology
|
|
|
Medical education |
- Medical school
- Bachelor of Medicine, Bachelor of Surgery
- Bachelor of Medical Sciences
- Master of Medicine
- Master of Surgery
- Doctor of Medicine
- Doctor of Osteopathic Medicine
- MD–PhD
|
|
Related topics |
- Allied health
- Nanomedicine
- Molecular oncology
- Personalized medicine
- Veterinary medicine
- Physician
- History of medicine
|
|
|
Concepts in pharmacology
|
|
Pharmacokinetics |
- (L)ADME: (Liberation)
- Absorption
- Distribution
- Metabolism
- Excretion (Clearance)
- Loading dose
- Volume of distribution (Initial)
- Rate of infusion
- Compartment
- Bioequivalence
- Bioavailability
- Onset of action
- Biological half-life
- Mean residence time
- Plasma protein binding
- Therapeutic index (Median lethal dose, Effective dose)
|
|
Pharmacodynamics |
- Mechanism of action
- Toxicity (Neurotoxicology)
- Dose–response relationship (Efficacy, Potency)
- Antimicrobial pharmacodynamics: Minimum inhibitory concentration (Bacteriostatic)
- Minimum bactericidal concentration (Bactericide)
|
|
Agonism and
antagonism |
- Agonist: Inverse agonist
- Irreversible agonist
- Partial agonist
- Superagonist
- Physiological agonist
- Antagonist: Competitive antagonist
- Irreversible antagonist
- Physiological antagonist
- Other: Binding
- Affinity
- Binding selectivity
- Functional selectivity
|
|
Other |
- Drug tolerance: Tachyphylaxis
- Drug resistance: Antibiotic resistance
- Multiple drug resistance
|
|
Drug discovery
strategies |
|
|
Related
fields/subfields |
- Pharmacogenetics
- Pharmacogenomics
- Neuropsychopharmacology (Neuropharmacology, Psychopharmacology)
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience.
- Sriskandarajah P1,2, Pawlyn C1,2, Mohammed K1, Dearden CE1, Davies FE1,3, Morgan GJ1,3, Boyd KD1, Kaiser MF1,2.
- Leukemia & lymphoma.Leuk Lymphoma.2017 Feb;58(2):494-497. Epub 2016 Jul 20.
- PMID 27439571
- A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
- Rathod LV1, Kapadia R1, Sawant KK2.
- Materials science & engineering. C, Materials for biological applications.Mater Sci Eng C Mater Biol Appl.2017 Feb 1;71:529-540. doi: 10.1016/j.msec.2016.10.017. Epub 2016 Oct 15.
- The present investigation was carried out to demonstrate with the help of in vitro and in vivo studies that nanoparticles impregnated ocular inserts effectively delivers significant concentration of drug to the posterior segment of eye after topical administration for treatment of glaucoma. Drug loa
- PMID 27987741
- Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
- De Bellis M1, Carbonara R1, Roussel J1, Farinato A1, Massari A1, Pierno S1, Muraglia M2, Corbo F2, Franchini C2, Carratù MR3, De Luca A1, Conte Camerino D1, Desaphy JF4.
- Neuropharmacology.Neuropharmacology.2017 Feb;113(Pt A):206-216. doi: 10.1016/j.neuropharm.2016.10.013. Epub 2016 Oct 13.
- Although the sodium channel blocker, mexiletine, is the first choice drug in myotonia, some myotonic patients remain unsatisfied due to contraindications, lack of tolerability, or incomplete response. More therapeutic options are thus needed for myotonic patients, which require clinical trials based
- PMID 27743929
Japanese Journal
- 残遺型,多剤併用,多量投与,治療抵抗性又は高齢の統合失調症患者を対象にasenapine舌下錠を52週間投与した場合の安全性及び有効性を検討する第Ⅲ相試験(P06238試験)
- 統合失調症患者を対象にasenapine舌下錠を52週間投与した場合の安全性及び有効性を検討する第Ⅲ相延長投与試験(P06125試験)
Related Links
- tolerability 【名】耐性、耐容性、認容性、許容性、忍容性 - アルクがお届けする進化するオンライン英和・和英辞書データベース。一般的な単語や連語から、イディオム、専門用語、スラングまで幅広く収録。
- "safety and tolerability" への豊富な翻訳例文 – 和英辞書と日本語翻訳サーチエンジン ... また、これまでと同様、 患者さんの安全性を最優先 に考え、ピオグリタゾンを含む全ての当社製品に 関 す る安全性と 忍容 性 の評価を継続する ...
★リンクテーブル★
[★]
- 関
- accept、acceptability、acknowledge、admission、approval、approve、authorization、tolerability、tolerant
[★]
- 英
- tolerability、acceptability、acceptance、tolerant
- 関
- 受け入れ、寛容、寛容性、許容度、承認、受諾、耐性、耐容性、許容性、受理、耐用性
[★]
- 英
- tolerance、tolerability、allowance、permissivity
- 関
- 寛容、寛容性、許容、耐性、耐容性、認容性、耐容能、許容性、トレランス、耐用性
[★]
- 関
- acceptability、acceptance、permissiveness、resistance、resistant、tolerability、tolerance
[★]
- 関
- allow、permission、permissivity、permit、sanction、tolerability、tolerance、tolerate